Disclaimers Content and Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment
Are Glucagon-like peptide-1 (GLP-1) receptor agonists Central Nervous System (CNS) penetrant: a narrative review
This information helps clinicians determine whether symptoms are likely related to GLP-1 therapy, represent expected consequences of weight loss, or suggest an alternative diagnosis requiring specific investigation
10.1007/s10561-022-10021-9 122
The findings of Thursdays JAMA study come as both Novo Nordisk and Lilly face legal challenges
Get GLP-1 Medications through Hims Hims & Hers are the same company, but Hers tends to focus on healthcare for women, while Hims focuses on treatments for men, including conditions like erectile dysfunction